2026 Michigan Medical Device Summit
Wednesday, September 30, 2026
Washtenaw Community College, Ann Arbor
This event is presented in partnership with
Where Michigan's Medical Device Ecosystem Connects, Innovates, and Grows
Join Michigan's premier Medical Device Summit to explore cutting-edge technologies, regulations, and industry insights. Network with top industry professionals, medtech innovators, researchers, manufacturing suppliers, investors, and government officials. Discover Michigan's thriving medtech ecosystem and its impact on innovation and economic growth.
REGISTER TODAY
WHY ATTEND?
Gain Strategic Insights – Learn about emerging technologies, regulatory updates, market trends, and industry best practices.
Build Valuable Connections – Network with medtech leaders, innovators, manufacturers, investors, and service providers.
Accelerate Innovation – Discover resources, partnerships, and opportunities that support product development and commercialization.
WHO SHOULD ATTEND?
Join us if you are:
- Industry executives and KOLs in the medtech sector
- Medtech product development experts
- Professionals in contract manufacturing, prototyping, or related services
- Medtech innovators
- Academic professionals engaged in medtech education
- Service specialists — regulatory, legal/IP, other providers
Be part of the conversation driving Michigan's medical technology cluster, and engage in intrastate partnering.
KEYNOTE SPEAKER
Michelle Tarver, MD, PhD
Director - Center for Devices and Radiological Health
U.S. Food & Drug Administration
Dr. Michelle Tarver is Director of the FDA's Center for Devices and Radiological Health (CDRH), where she leads the Center's efforts to advance public health through innovative, safe, and effective medical devices. A board-certified ophthalmologist with a PhD in epidemiology, she has more than 15 years of experience at the FDA, holding leadership roles spanning medical device regulations, strategic innovation, patient engagement, and evidence generation.
Throughout her career, Dr. Tarver has led initiatives to strengthen collaboration across the healthcare ecosystem, elevate the patient perspective in regulatory decision-making, and advance innovative approaches to medical device evaluation. She has extensive experience in clinical research, regulatory policy, and premarket and postmarket review.
Dr. Tarver earned a B.S. in Biochemistry from Spelman College and completed the M.D./Ph.D. program at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. She continues to practice as a clinician caring for patients with inflammatory eye conditions.
Conference Agenda Highlights
C-Suite Unplugged: The Future of Medtech: Navigating Transformation in an Era of AI, Regulation, and Global Competition
Medical technology is entering a period of unprecedented change. AI-enabled devices, evolving regulatory expectations, shifting supply chains, and mounting pressure to demonstrate value are reshaping the industry's future. This executive leadership panel explores the strategic decisions manufacturers are making today to remain competitive and drive innovation tomorrow.
Advancing Innovation, Ensuring Trust: A Conversation with FDA CDRH Director Dr. Michelle Tarver
As medical technology becomes increasingly sophisticated—from AI-enabled diagnostics and digital therapeutics to connected devices and advanced manufacturing—the role of regulatory leadership has never been more critical. Join Dr. Michelle Tarver, Director of the FDA's Center for Devices and Radiological Health (CDRH), for an engaging fireside chat exploring the agency's vision for fostering innovation while ensuring patient safety and public confidence. The discussion will examine emerging regulatory priorities, the future of AI oversight, opportunities to accelerate patient access to breakthrough technologies, and how FDA is partnering with industry to shape the next generation of medical devices.
Medtech at a Crossroads: Policy, Power, and the Fight for Innovation
From FDA reform and reimbursement pressures to global competition and supply chain security, policy decisions are increasingly determining which technologies reach patients - and which companies thrive. In this candid conversation, Greg Crist of AdvaMed explores the forces shaping the future of medtech and what industry leaders must do to ensure innovation remains a national priority.
MORE Information on additional sessions to be announced soon.
-
WHAT PREVIOUS ATTENDEES ARE SAYING
Manufacturer Perspective
“The Medical Device Summit was packed with actionable insights. The C-Suite Unplugged discussion was so informative, while the session on AI-Powered Healthcare gave a dynamic view of the future. It’s rare to find such concentrated, high-level content in one place. This event has become a must-attend for staying visible in Michigan’s medtech sector.”
-
WHAT PREVIOUS ATTENDEES ARE SAYING
Innovator/Startup Voice
“As a first-time founder navigating Michigan’s medtech landscape, this summit was a game-changer. I gained critical insights from regulatory experts, met funding partners, and had meaningful conversations with contract manufacturers and other startups. I walked away with real leads, ideas, and renewed confidence in our commercialization path.”
-
WHAT PREVIOUS ATTENDEES ARE SAYING
Contractor/Supplier Insights
“The summit provided an unparalleled opportunity to connect with OEMs and service partners, and prospective clients all in one place. The sessions on manufacturing automation and regulatory alignment were especially valuable for streamlining our upcoming product line. We’re already planning to bring more of our team next year.”
-
WHAT PREVIOUS ATTENDEES ARE SAYING
Regulatory Expert Take
“The summit hit all the hot-button regulatory topics. Between the in-depth sessions on biocompatibility, premarket submissions, and QMSR alignment with ISO 13485, and the capstone FDA Town Hall, there was no shortage of clarity or candid feedback. It was a goldmine for medtech professionals.”
